Contact Us
Subscribe
e-Edition

Dashboard
Logout

- My Account
- Dashboard
- Profile
- Saved items
- Logout

Facebook

38°
- Decatur, IN (46733)
  Today
  
  Plenty of sunshine. High 59F. Winds SW at 10 to 20 mph..
  
  Tonight
  
  Mainly clear. Low 34F. Winds WSW at 10 to 20 mph.
  
  Updated: February 27, 2026 @ 8:42 am
- Full Forecast

Site search

Home
News
Sports
Obituaries
Classifieds
- Place an ad
E-Edition
Best of 2024

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Allogene Therapeutics, Inc. - Common Stock (NQ:ALLO)

2.485 -0.245 (-8.97%)

Streaming Delayed Price Updated: 9:35 AM EST, Feb 27, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Allogene Therapeutics, Inc. - Common Stock

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Allogene Therapeutics Presents Preclinical Data on Next Generation Cloak™ and Dagger™ Technologies at the Society for Immunotherapy of Cancer Annual Meeting

November 03, 2023

From Allogene Therapeutics, Inc.

Via GlobeNewswire

Allogene Therapeutics Presents Preclinical Data on a Novel Allogeneic CAR T Product Candidate Targeting Claudin18.2 at the Society for Immunotherapy of Cancer Annual Meeting

November 03, 2023

From Allogene Therapeutics, Inc.

Via GlobeNewswire

Expedia Group, Gartner, Cloudflare, Cardinal Health And Other Big Stocks Moving Higher On Friday ↗

November 03, 2023

U.S. stocks traded higher, with the Dow Jones gaining around 200 points on Friday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Topics Stocks

Earnings Outlook For Allogene Therapeutics ↗

November 01, 2023

Via Benzinga

Allogene Therapeutics Reports Third Quarter 2023 Financial Results and Business Update

November 02, 2023

From Allogene Therapeutics, Inc.

Via GlobeNewswire

Allogene Therapeutics Announces Poster Presentations at the 65th Annual Meeting of the American Society of Hematology

November 02, 2023

From Allogene Therapeutics, Inc.

Via GlobeNewswire

Allogene Therapeutics Announces Participation in November Investor Conferences

October 30, 2023

From Allogene Therapeutics, Inc.

Via GlobeNewswire

Analyst Ratings for Allogene Therapeutics ↗

September 25, 2023

Via Benzinga

Earnings Outlook For Allogene Therapeutics ↗

August 01, 2023

Via Benzinga

Analyst Ratings for Allogene Therapeutics ↗

June 16, 2023

Via Benzinga

Why Allogene Stock Is Trading Down Today ↗

June 14, 2023

Allogene Therapeutics, Inc. (NASDAQ: ALLO) shares are trading lower after the company announced its CFO Eric Schmidt will step down from his position.

Via Benzinga

Allogene Therapeutics to Report Third Quarter 2023 Financial Results on November 2, 2023

October 26, 2023

Conference Call and Webcast Scheduled for 2:00 PM PT/5:00 PM ET

From Allogene Therapeutics, Inc.

Via GlobeNewswire

Allogene Therapeutics Appoints Geoffrey Parker as Chief Financial Officer

October 16, 2023

From Allogene Therapeutics, Inc.

Via GlobeNewswire

A Bull Market Is Coming: 1 Beaten-Down Growth Stock You Could Regret Not Buying on the Dip ↗

October 10, 2023

Wall Street price targets suggest this stock can rocket more than 400% higher.

Via The Motley Fool

Vail Resorts, Carnival, Opera And Other Big Stocks Moving Lower On Friday ↗

September 29, 2023

U.S. stocks traded higher, with the Nasdaq Composite gaining around 1% on Friday. Here are some big stocks recording losses in today’s session. Corcept Therapeutics Incorporated (NASDAQ: CORT) shares...

Via Benzinga

Topics Stocks

Allogene Therapeutics Announces Three Poster Presentations from its Next Generation AlloCAR T™ Platform at the Society for Immunotherapy of Cancer (SITC) Annual Meeting

September 27, 2023

From Allogene Therapeutics, Inc.

Via GlobeNewswire

Allogene Therapeutics Announces Participation in September Investor Conference

September 05, 2023

From Allogene Therapeutics, Inc.

Via GlobeNewswire

The Next Meme Stock: 6 Tickers Leading a Meme Stock Revival

August 18, 2023

Meme stocks soared during the early days of the pandemic. Will these stocks form a major meme stock rally or a short-lived farewell tour? Learn more.

Via MarketBeat

Allogene Therapeutics Appoints Earl Douglas as General Counsel

August 14, 2023

From Allogene Therapeutics, Inc.

Via GlobeNewswire

Allogene Therapeutics Reports Second Quarter 2023 Financial Results and Business Update

August 02, 2023

From Allogene Therapeutics, Inc.

Via GlobeNewswire

3 Stocks With Sky-High Short Interest Levels

July 31, 2023

BYND, BTAI, and ALLO stand out as high short-interest stocks to watch due to their potential for price fluctuations and short-squeeze opportunities.

Via MarketBeat

Allogene Therapeutics to Report Second Quarter 2023 Financial Results on August 2, 2023

July 26, 2023

From Allogene Therapeutics, Inc.

Via GlobeNewswire

Short Squeeze Alert: The 5 Most Shorted Stocks Right Now ↗

June 22, 2023

Wondering what are the most shorted stocks this year? Here are the top five companies investors are betting against.

Via InvestorPlace

Allogene Therapeutics' Allogeneic CAR-T Therapy Proves Potential for LBCL Treatment, Analysts See Potential for First-in-Class Status ↗

June 16, 2023

Thursday, Allogene Therapeutics Inc (NASDAQ: ALLO) presented the updated data from the Phase 1 ALPHA/ALPHA2 trials of ALLO-501/501A in 33 CAR T naïve patients with relapsed/refractory (r/r) large...

Via Benzinga

Allogene Therapeutics Provides Additional ALLO-501/501A Phase 1 Data in an Oral Presentation at the International Conference on Malignant Lymphoma (ICML) Lugano

June 15, 2023

From Allogene Therapeutics, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

June 14, 2023

Via Benzinga

Why MIND Technology Shares Are Trading Lower By Over 20%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

June 14, 2023

Gainers WeTrade Group, Inc. (NASDAQ: WETG) shares climbed 140.3% to $20.28. WeTrade launched large-scale language processing models to increase product applications in the field of artificial...

Via Benzinga

Allogene Therapeutics Announces Departure of Chief Financial Officer

June 14, 2023

From Allogene Therapeutics, Inc.

Via GlobeNewswire

Allogene Therapeutics Announces Oral Presentation of Phase 1 Data on ALLO-501/501A in Large B Cell Lymphoma at the International Conference on Malignant Lymphoma (ICML) Lugano

June 09, 2023

From Allogene Therapeutics, Inc.

Via GlobeNewswire

Allogene Therapeutics Presents Updated ALLO-501/501A Phase 1 Data in Large B Cell Lymphoma at the American Society of Clinical Oncology (ASCO) Annual Meeting

June 03, 2023

From Allogene Therapeutics, Inc.

Via GlobeNewswire

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

Home
Announcements
News
Sports
Entertainment
Local Events
Obituaries
Multimedia
Online Features

Services

Subscription Services
Submission Forms
Classifieds
Place an Ad
Promote Your Event
Email Alerts
Search
Weather

Decatur Daily Democrat

DecaturDailyDemocrat.com
141 S. Second Street
Decatur, IN 46733
Phone: 260-724-2121
Email: reporter@decaturdailydemocrat.com

Facebook

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Decatur, IN (46733)

Today

Tonight

Allogene Therapeutics, Inc. - Common Stock (NQ:ALLO)

All News about Allogene Therapeutics, Inc. - Common Stock

Sections

Services

Decatur Daily Democrat